# Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial

Study · id `cardio:ct-nct03044184` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03044184](<https://clinicaltrials.gov/study/NCT03044184>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03044184

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.

## Technical summary

Registry record NCT03044184. Randomized; double masking; primary purpose treatment. Start 2017-04-01 (actual); primary completion 2020-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 220 participants (planned count; ClinicalTrials.gov record NCT03044184, source copy `cardio:ctgov-nct03044184-2019-10-17`, retrieved 2026-10-26)
- Started: 2017-04-01 (actual) (ClinicalTrials.gov record NCT03044184, source copy `cardio:ctgov-nct03044184-2019-10-17`, retrieved 2026-10-26)
- Primary completion: 2020-06-30 (anticipated) (ClinicalTrials.gov record NCT03044184, source copy `cardio:ctgov-nct03044184-2019-10-17`, retrieved 2026-10-26)
- Completion: 2020-12-31 (anticipated) (ClinicalTrials.gov record NCT03044184, source copy `cardio:ctgov-nct03044184-2019-10-17`, retrieved 2026-10-26)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT03044184, source copy `cardio:ctgov-nct03044184-2019-10-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03044184-2019-10-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial
- Acronym: TRANSACT
- Condition: Stroke Hemorrhagic
- Condition: Intracerebral Haemorrhage
- Intervention (Drug): Tranexamic Acid
- Lead sponsor: Kwong Wah Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 9b2424d586689f3908765b4b764d704e50471df13386f1d2a7d804605fe5529a
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
